Draft — pending clinical review
This article is in editorial draft. It has been researched against current AACAP 2022 clinical practice guidelines, the landmark TADS trial, CDC NHANES 2021–2023 data, and NIMH adolescent statistics — but every clinical claim, particularly around diagnosis, treatment efficacy, medication, and suicidality, must be verified by Hartley's medical reviewer before publication. Markers labeled {CLINICAL REVIEW NEEDED} appear throughout, indicating the specific claims that need clinician sign-off.
If your teen is in immediate crisis — talking about suicide, having thoughts of self-harm they can't manage, or unable to function — call or text 988 right now, or go to your nearest emergency department. The rest of this page assumes the situation is less acute and you have time to read.
What teen depression actually is
Clinical depression in adolescents is not the same as sadness, moodiness, or the normal emotional intensity of being a teenager. {CLINICAL REVIEW NEEDED}: The DSM-5 defines major depressive disorder by the presence of either persistent depressed or irritable mood, or marked loss of interest or pleasure, lasting most of the day nearly every day for at least two weeks, accompanied by additional symptoms that affect sleep, appetite, energy, concentration, self-worth, or thoughts of death.
Two things make adolescent depression particularly easy to miss. The first is that in teens specifically, depressed mood can present as irritability rather than sadness — the DSM-5 explicitly recognizes this. A teen who has become uncharacteristically hostile, easily frustrated, or angry may be depressed rather than simply going through a difficult phase. The second is that the functional impairment is often visible only inside the home; many depressed teens still go to school, still see friends, still appear to function on the surface, while the family sees the collapse at home.
The clinical question is not whether your teen feels sad. It's whether what they're experiencing is persistent enough, severe enough, and impairing enough to meet diagnostic criteria — and whether it warrants treatment regardless of whether it does.
The depressive disorders in adolescents
Depression isn't a single disorder. The DSM-5 defines several distinct depressive disorders that present in adolescents, each with different patterns and treatment implications. The most relevant to families are:
- Major Depressive Disorder (MDD) — the most common diagnosis, characterized by discrete episodes of significantly impaired mood and functioning lasting at least two weeks.
- Persistent Depressive Disorder (PDD) — formerly called dysthymia. A more chronic, lower-grade depression lasting at least one year in adolescents, often beginning in childhood and going undetected for years because there is no clear "episode."
- Disruptive Mood Dysregulation Disorder (DMDD) — a diagnosis added in DSM-5 for children and adolescents with chronic, severe irritability and frequent temper outbursts. Distinct from bipolar disorder.
- Bipolar Disorder — characterized by episodes of mania or hypomania alongside depressive episodes. Less common in adolescents than unipolar depression, often misdiagnosed in both directions.
- Premenstrual Dysphoric Disorder (PMDD) — severe, cyclical mood symptoms tied to the menstrual cycle. Distinct from premenstrual syndrome and increasingly recognized in adolescent girls.
This article focuses primarily on major depressive disorder in adolescents — the condition most parents are searching when they reach Hartley. The other conditions are covered in their own deep-dive articles in this cluster.
Why adolescent depression looks different from adult depression
A few things make adolescent depression distinct, and worth understanding for parents. {CLINICAL REVIEW NEEDED}.
Adult depression typically
- Presents as persistent sadness or flatness
- Unrelenting — doesn't lift much with positive events
- Insomnia and weight loss
- Internal experience described directly
- Often a discrete first episode
Adolescent depression often
- Presents as irritability, hostility, or anger
- Reactive — lifts briefly with good events, returns
- Hypersomnia (10–14 hrs) and increased appetite
- Shown through visible behavior change, not described
- Comorbidity is the rule, not the exception
A teen who has become uncharacteristically hostile, easily frustrated, or angry may be depressed rather than simply going through a difficult phase.
Irritability often replaces sadness. The DSM-5 specifically recognizes that depressed mood in children and adolescents can present as irritability. A depressed teen may not look sad — they may look angry. The teenager who used to be easygoing and is now snappy, hostile, or constantly frustrated may be depressed, not "going through a phase."
Reactivity is preserved more than in adults. Adults with depression often describe an unrelenting flatness that doesn't lift even with positive events. Adolescents with depression frequently still respond to good things — a fun afternoon with friends, a favorite show, a small win at school — but return to depressed mood when the positive moment ends. This can lead parents and even some clinicians to dismiss the depression as "not real," when the reactive pattern is in fact characteristic of adolescent presentations.
Sleep and appetite changes often go the other direction. Adult depression classically presents with insomnia and weight loss. Adolescent depression more often presents with hypersomnia (sleeping 10–14 hours, struggling to wake) and increased appetite or weight gain. The "tired all the time, can't get out of bed, eating in their room" pattern is the more typical adolescent presentation.
Academic and social withdrawal are core signs. Where adults often describe their depression through internal experience, adolescents often show it through visible changes: dropping out of activities they used to love, withdrawing from friends, declining grades, refusing to participate in family life. These behavior changes are often the first thing parents notice, and they are clinically significant.
Comorbidity is the rule, not the exception. Adolescent depression frequently co-occurs with anxiety (estimated 30–75% comorbidity, depending on the study), substance use, ADHD, eating disorders, and trauma-related disorders. This affects diagnosis (one condition can mask another) and treatment (which to address first, and how).
Suicide risk is real and elevated. Suicide is among the leading causes of death in U.S. adolescents, and depression is the largest modifiable risk factor. This is the reason adolescent depression is treated as urgent rather than something to wait out — the consequences of untreated depression at this age can be irreversible.
Why this matters
The "tired all the time, can't get out of bed, eating in their room, snappy with everyone" pattern is the textbook adolescent presentation — not a phase, and not a discipline problem. Recognizing the pattern is most of the work.
What evidence-based treatment actually looks like
There are three treatments with strong evidence for adolescent depression: cognitive behavioral therapy (CBT), interpersonal therapy for adolescents (IPT-A), and the SSRI fluoxetine. Each has a clear evidence base, and they are often used in combination.
Cognitive Behavioral Therapy (CBT)
CBT for adolescent depression focuses on identifying and changing the patterns of thinking and behavior that maintain depression — cognitive distortions, behavioral withdrawal, problem-solving deficits. {CLINICAL REVIEW NEEDED}: AACAP's 2022 Clinical Practice Guideline recommends CBT as one of two evidence-based psychotherapies for adolescents with major depressive disorder.
The landmark Treatment for Adolescents with Depression Study (TADS), conducted at 13 U.S. clinical sites and published in JAMA in 2004, randomized 439 adolescents with major depression to four conditions: CBT alone, fluoxetine alone, combination CBT and fluoxetine, or placebo. At 12 weeks, the response rates were 71% for combination treatment, 61% for fluoxetine alone, 43% for CBT alone, and 35% for placebo. By 36 weeks, all active treatments converged on approximately 80% response — but combination treatment reached that level fastest.
What this means in practice: CBT alone works for many adolescents, particularly those with mild-to-moderate depression. For moderate-to-severe depression, the evidence supports combination treatment with medication.
Interpersonal Therapy for Adolescents (IPT-A)
IPT-A focuses on the relationship problems that often accompany — and frequently maintain — adolescent depression: grief, role transitions, interpersonal conflict, and interpersonal deficits. AACAP's 2022 guideline includes IPT-A alongside CBT as a recommended psychotherapy for adolescent depression.
IPT-A is less widely available than CBT, but for adolescents whose depression is closely tied to relational stressors — a recent breakup, parental divorce, peer conflict, the death of a family member — it may be the better fit. The evidence base is smaller than for CBT but consistent.
Fluoxetine and SSRIs
Fluoxetine (brand name Prozac) is the only SSRI with FDA approval specifically for the treatment of major depressive disorder in adolescents (ages 8 and older). Escitalopram (Lexapro) is approved for ages 12 and older. Other SSRIs are sometimes prescribed off-label in adolescents based on the prescriber's clinical judgment.
{CLINICAL REVIEW NEEDED}: AACAP's 2022 guideline suggests that for adolescents with moderate to severe major depressive disorder, fluoxetine should be considered as part of treatment, often in combination with CBT. The TADS data support this: combination treatment outperformed either monotherapy in speed of response and in protecting against treatment-emergent suicidal ideation.
The FDA black box warning
In 2004, the FDA issued a black box warning on antidepressants for patients under 18, based on a meta-analysis that found small increases in suicidal thinking and behavior in adolescents and young adults taking SSRIs compared to placebo (approximately 4% versus 2%). The warning was extended to young adults up to age 24 in 2007.
The warning has been controversial. {CLINICAL REVIEW NEEDED}: After the warning was issued, SSRI prescriptions for adolescents declined substantially. Some research suggests that adolescent suicide rates rose during the same period, raising concerns that the warning may have unintentionally reduced access to effective treatment. Other research has reinforced the original signal of treatment-emergent suicidality in young patients.
What most clinicians take from this: the risk of treatment-emergent suicidality is real but small, it appears most often in the first weeks of treatment, and it is reduced when SSRIs are combined with CBT and with close clinical monitoring. The risk of untreated moderate-to-severe adolescent depression — including the elevated risk of completed suicide — is generally considered greater than the risk of medication when used appropriately.
This is not a decision to make alone or in haste. A child psychiatrist who can evaluate the specific presentation, family history, and risk factors is the right partner.
When higher levels of care are warranted
Most adolescent depression is treated effectively in outpatient settings — weekly therapy, possibly with medication, with the teen continuing to live at home and attend school. But some presentations require more intensive care, in roughly this order of intensity:
The decision about level of care is a clinical judgment, ideally made by a clinician who isn't financially tied to a specific program. We cover the levels of care in detail in our pillar guide, and the decision-stage cluster covers the harder family questions about residential treatment specifically.
What parents can do at home
Treatment matters. So does the daily environment around it. A few things consistently help, beyond formal clinical treatment:
Lower the conversational stakes. Depressed teens often shut down under direct questioning ("how are you feeling? what's wrong? what can I do?"). Many do better with side-by-side conversation — driving in the car, walking the dog, cooking together — than with face-to-face emotional check-ins.
Protect sleep. Adolescent depression and adolescent sleep deprivation reinforce each other. Phones out of the bedroom at night, consistent wake times, and limits on late-night gaming or social media use are not "screen time policing" — they're depression treatment.
Maintain structure without rigidity. Depressed teens benefit from predictable routine — meals, exercise, daylight, sleep — but power struggles over rigid expectations can backfire. The goal is gentle structure, not enforcement.
Don't accept total withdrawal as inevitable. Behavioral activation is one of the core components of CBT for depression: getting depressed people doing things, even small things, even when they don't feel like it. Parents can support this by inviting (not demanding) participation in low-stakes activities.
Manage your own response. Watching a depressed teen is genuinely painful, and parents' own anxiety can spill onto the teen in ways that make things worse. Therapy for parents, support groups for parents of teens with mental health challenges, and your own care matter.
Secure access to lethal means. If your teen has expressed any thoughts about suicide, or is being treated for moderate-to-severe depression, the standard recommendation is to remove or secure firearms in the home and to lock or remove access to medications. This is not a comment on your teen or your parenting — it is a basic harm-reduction step backed by extensive research showing that limiting access to lethal means reduces completed suicides.
How Hartley is going to cover this cluster
This hub page is the entry point. The deep-dive subpages for major depressive disorder, persistent depressive disorder, bipolar disorder in adolescents, CBT and IPT-A for depression, and SSRIs and the black box warning are in production. Each will follow the same standards as our existing anxiety cluster: named clinical reviewer before publication, real sourced citations, clear flagging of where the evidence is strong and where it isn't.
If you're a clinician who works with adolescent depression and you'd be willing to review draft articles in this cluster, we're hiring. See our medical review page.
Common questions